NEW YORK ( TheStreet) -- Shares of Chindex International (Nasdaq: CHDX) have taken a tremendous swing upward. The stock is trading at $10.09 as of 10:51 a.m. ET, 20.1% above Monday's closing price of $8.40. Volume is at 51,498, 0.9 times the daily average of 56,300. Chindex International has a market cap of $124.9 million and is part of the services sector and wholesale industry. Shares are down 49.1% year to date as of the close of trading on Monday. Chindex International, Inc. engages in the provision of healthcare services; and sale of medical equipment, instrumentation, and products. The company operates in two segments, Healthcare Services and Medical Products. The company has a P/E ratio of 15.7, below the average wholesale industry P/E ratio of 22.6 and below the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Chindex International as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. You can view the full Chindex International Ratings Report. See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center. Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.
More from Markets
Jim Cramer Breaks Down the Biggest Impacts of the CEO Shuffle
Jim Cramer weighs in Nike, Under Armour, and ServiceNow's CEO shakeups.
Here Are the Two Biggest Headwinds Stocks Are Facing, as Global Stocks Rebound
The big issue for U.S. stocks is Caterpillar's unfortunate quarter. Here's why that scares the broader market.
Zuckerberg: Facebook Won't Be 'Part of' Launching Libra Without Approval
The social network's co-founder and CEO was grilled on Libra and a range of other issues before the House Financial Services Committee.
Jim Cramer: Why Texas Instruments Isn't the Bellwether the Market Wants It to Be
Let's talk about the Texas Instruments quarter.